| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 234.60B | 236.54B | 236.39B | 223.52B | 176.23B | 190.52B |
| Gross Profit | 8.97B | 25.63B | 4.06B | -47.88B | 3.35B | 13.16B |
| EBITDA | 32.40B | 30.50B | 25.05B | -28.47B | 26.38B | 34.97B |
| Net Income | 5.83B | 4.32B | 2.39B | -45.46B | 1.96B | 8.34B |
Balance Sheet | ||||||
| Total Assets | 504.13B | 502.18B | 500.24B | 481.80B | 447.70B | 428.40B |
| Cash, Cash Equivalents and Short-Term Investments | 20.66B | 18.75B | 22.16B | 19.06B | 21.87B | 26.68B |
| Total Debt | 320.86B | 312.22B | 314.47B | 304.62B | 227.64B | 211.34B |
| Total Liabilities | 382.03B | 378.63B | 381.40B | 367.30B | 286.41B | 265.33B |
| Stockholders Equity | 119.91B | 121.36B | 116.80B | 112.61B | 159.48B | 161.43B |
Cash Flow | ||||||
| Free Cash Flow | -5.41B | -7.04B | -7.72B | -81.14B | -18.64B | 400.00M |
| Operating Cash Flow | 4.67B | 34.08B | 25.63B | -38.06B | 17.33B | 31.69B |
| Investing Cash Flow | -8.51B | -34.04B | -32.00B | -38.48B | -34.93B | -29.48B |
| Financing Cash Flow | 4.94B | -3.44B | 9.54B | 75.04B | 12.79B | 1.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥584.27B | 5.14 | 16.40% | 3.47% | -8.73% | -6.98% | |
71 Outperform | ¥224.00B | 13.52 | 13.70% | 2.36% | -1.60% | -10.41% | |
69 Neutral | ¥222.54B | 4.18 | 17.23% | 2.31% | 1.75% | 38.58% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
65 Neutral | ¥359.29B | 16.42 | 12.27% | 3.23% | -1.02% | 79.80% | |
63 Neutral | ¥58.01B | 3.56 | 4.73% | 2.31% | -1.96% | 33.15% | |
52 Neutral | ¥1.02T | 5.29 | -22.13% | ― | -2.28% | -794.92% |